Stay updated on Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The study record now includes posted results with a new 'Results First Posted' date (2025-01-27) and updated QC-related study dates.
    Difference
    0.3%
    Check dated 2025-11-03T01:34:47.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Update: page version bumped to v3.2.0 with an added government operating status notice; removal of the v3.1.0 tag. Overall, signals a status and version update rather than a change to core content.
    Difference
    2%
    Check dated 2025-10-05T12:49:15.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Upgrade version from v3.0.2 to v3.1.0; no other content changes are specified.
    Difference
    0.0%
    Check dated 2025-09-28T09:34:01.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2, indicating a minor update; the 'Back to Top' navigation element was removed.
    Difference
    0.1%
    Check dated 2025-09-14T00:09:36.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-06T17:49:24.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility names and locations, specifically adding details about Trastuzumab Deruxtecan and various related medical terms, while removing some previous location references and specific drug categories.
    Difference
    3%
    Check dated 2025-08-30T15:24:53.000Z thumbnail image

Stay in the know with updates to Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial page.